| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Huntington s diseaseWilson s diseaseFahr s diseaseTetrabenazineOrganelle migrationAutophagyTrinucleotide repeatNervous system (Neurodegeneration)RapamycinProteasomeHeat shock responseHSF1Hypersexuality| 1 | 1998 | Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature. | 
| + | - | nl | Can J Psychiatry 43(9):933-40 (1998) |
| 2 | 1998 | Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. | 
| + | - | nl | J Neuropsychiatry Clin Neurosci 10(3):249-66 (1998) |
| 3 | 2007 | Tetrabenazine in the treatment of Huntington's disease. | 
| + | - | nl | Neuropsychiatr Dis Treat 3(5):545-51 (2007) |
| 4 | 2007 | Neuropsychiatry of Huntington's disease. | 
| + | - | nl | Dialogues Clin Neurosci 9(2):191-7 (2007) |
| 5 | 2005 | Development of novel therapies for Huntington's disease: hope and challenge. | 
| + | - | nl | Acta Pharmacol Sin 26(2):129-42 (2005) |
| 6 | 2004 | Huntingtin processing in pathogenesis of Huntington disease. | 
| + | - | nl | Acta Pharmacol Sin 25(10):1243-9 (2004) |
| 7 | 1999 | Are there multiple pathways in the pathogenesis of Huntington's disease? | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 354(1386):995-1003 (1999) |
| 8 | 1982 | Huntington's chorea. Report of 3 cases and review of the literature. | 
| + | - | nl | Arch Dis Child 57(2):99-103 (1982) |
| 9 | 2007 | Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. | 
| + | - | nl | Arch Neurol 64(6):813-9 (2007) Ribai P |
| 10 | 2004 | Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. | 
| + | - | nl | Brain 127(Pt 6):1219-28 (2004) |
| 11 | 1966 | Huntington's chorea. | 
| + | - | nl | J Med Genet 3(4):298-314 (1966) |
| 12 | 2006 | Brain imaging and cognitive dysfunctions in Huntington's disease. | 
| + | - | nl | J Psychiatry Neurosci 31(1):21-9 (2006) |
| 13 | 1994 | Huntington's disease: pathogenesis, diagnosis and treatment. | 
| + | - | nl | J Psychiatry Neurosci 19(5):359-67 (1994) |
| 14 | 2006 | Multiple pathways contribute to the pathogenesis of Huntington disease. | 
| + | - | nl | Mol Neurodegener 1(-):19 (2006) |
| 15 | 2001 | Huntington's disease. | 
| + | - | nl | Mol Pathol 54(6):409-13 (2001) |
| 16 | 2004 | Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. | 
| + | - | nl | NeuroRx 1(2):263-72 (2004) |
| 17 | 2004 | Huntington's disease genetics. | 
| + | - | nl | NeuroRx 1(2):255-62 (2004) |
| 18 | 2004 | The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration. | 
| + | - | nl | NeuroRx 1(1):128-38 (2004) |
| 19 | 1973 | Huntington's chorea: a centenary review. | 
| + | - | nl | Postgrad Med J 49(567):32-45 (1973) |
| 20 | 2008 | Huntington disease models and human neuropathology: similarities and differences. | 
| + | - | nl | Acta Neuropathol 115(1):55-69 (2008) |
| 21 | 2010 | Impaired mitochondrial trafficking in Huntington's disease. | 
| + | - | nl | Biochim Biophys Acta 1802(1):62-5 (2010) |
| 22 | 2009 | Mouse models of Huntington's disease and methodological considerations for therapeutic trials. | 
| + | - | nl | Biochim Biophys Acta 1792(6):506-20 (2009) |
| 23 | 2009 | Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. | 
| + | - | nl | Cell Death Differ 16(1):46-56 (2009) |
| 24 | 2008 | The ubiquitin-proteasome pathway in Huntington's disease. | 
| + | - | nl | ScientificWorldJournal 8(-):421-33 (2008) |
| 25 | 2011 | The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. | 
| + | - | nl | J Clin Invest 121(2):476-83 (2011) |
| 26 | 2011 | Brain networks in Huntington disease. | 
| + | - | nl | J Clin Invest 121(2):484-92 (2011) |
| 27 | 2011 | Energy deficit in Huntington disease: why it matters. | 
| + | - | nl | J Clin Invest 121(2):493-9 (2011) |
| 28 | 2011 | Oligonucleotide therapeutic approaches for Huntington disease. | 
| + | - | nl | J Clin Invest 121(2):500-7 (2011) |
| 29 | 2011 | Shock and awe: unleashing the heat shock response to treat Huntington disease. | 
| + | - | nl | J Clin Invest 121(8):2972-5 (2011) |
| 30 | 2010 | Molecular mechanisms and potential therapeutical targets in Huntington's disease. | 
| + | - | nl | Physiol Rev 90(3):905-81 (2010) |
| 31 | 2011 | Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease. | 
| + | - | nl | Chang Gung Med J 34(2):135-52 (2011) |
| 32 | 2003 | Diagnosis of Huntington disease. | 
| + | - | nl | Clin Chem 49(10):1726-32 (2003) |
| 33 | 2010 | Huntington's disease: pathogenesis to animal models. | 
| + | - | nl | Pharmacol Rep 62(1):1-14 (2010) |
| 34 | 2011 | Hypersexual features in Huntington's disease. | 
| + | - | nl | Singapore Med J 52(6):e131-3 (2011) |